Source: Dr. Thomas Shrader
April 19, 2023 (Investorideas.com Newswire) Data show the vaccine elicited better immune responses in adults ages 50 and up than the...
Source: Yun Zhong
March 28, 2023 (Investorideas.com Newswire) Despite a competitor already on the market, the commercial opportunity for this particular treatm...